IHS Global Insight's Healthcare and Pharmaceuticals practice provides an independent, comprehensive range of analysis, forecasts, data, and consulting services for:
- Pharmaceutical manufacturers, wholesalers, and distributors
- Biotechnology research and development firms
- Generics manufacturers
- Healthcare policy makers and regulatory bodies
- Healthcare providers and insurers
- Financial institutions and professional services organizations
We can provide you with timely, insightful, and accurate analysis on the evolving regulatory and competitive landscape in more than 60 countries worldwide—enabling you to:
- Evaluate market opportunities and risks
- Monitor competitors and customers
- Assess the impact of a changing regulatory environment
- Plan and forecast budgets
- Stay up to date with recent industry developments and market trends
With our unique global perspective and regional expertise, we understand the forces in play—healthcare policy and regulatory developments, pharmaceutical pricing and reimbursement, industry-wide corporate strategies, and research and development trends,— and the ways they interact to influence your market opportunities.
Products and Services
IHS Global Insight Healthcare and Pharmaceuticals Experts
Our expert team provides an independent, fact-based view of the healthcare and pharmaceutical industry, fully supported by our 325+ economists and analysts worldwide with expertise in over 120 industries and 200 countries.
IHS Global Insight is the world leader in economic and financial analysis, forecasting, and market intelligence—with more than 40 years' experience and an outstanding record for accuracy.
|
